Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GI Adenocarcinoma”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Post-approval studies (Phase 4)Ended earlyNCT06077487
What this trial is testing

Ketamine-assisted Therapy for Advanced GI Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPain, AcuteGastrointestinal Cancers+1 more
Brian Anderson, MD 1
Testing effectiveness (Phase 2)Study completedNCT04197310
What this trial is testing

Cabozantinib and Nivolumab for Carcinoid Tumors

Who this might be right for
Carcinoid TumorCarcinoid Tumor of GI SystemNeuroendocrine Tumors
Dana-Farber Cancer Institute 19
Not applicableStudy completedNCT01249859
What this trial is testing

Prognosis of Signet Ring Cells in Upper Digestive Neoplasms

Who this might be right for
Signet Ring Cell CarcinomaStomach DiseaseOesophagus+2 more
University Hospital, Lille 2,500
Testing effectiveness (Phase 2)Ended earlyNCT02102022
What this trial is testing

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Who this might be right for
Advanced Gastrointestinal (GI) MalignanciesHepatocellular CarcinomaGastric Cancer+1 more
Polaris Group 140
Testing effectiveness (Phase 2)Study completedNCT03929666
What this trial is testing

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Who this might be right for
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals 74
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Not applicableLooking for participantsNCT04221893
What this trial is testing

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Who this might be right for
Stage IV Esophageal AdenocarcinomaStage IV Esophageal Squamous Cell CarcinomaStage IV Gastric Cancer+41 more
University of California, San Francisco 28
Not applicableStudy completedNCT05080088
What this trial is testing

Retrospective Evaluation of 3 Colonic Adenoma Detection Strategies

Who this might be right for
Adenoma ColonColorectal CancerColorectal Polyp+1 more
Centre Hospitalier Universitaire de Nīmes 90
Very early researchWithdrawnNCT03623984
What this trial is testing

Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Carcinoma of PancreasCarcinoid
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT01264705
What this trial is testing

Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
University of Texas Southwestern Medical Center 47
Testing effectiveness (Phase 2)Ended earlyNCT00012246
What this trial is testing

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+4 more
The University of Texas Medical Branch, Galveston 7
Not applicableLooking for participantsNCT06337760
What this trial is testing

YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.

Who this might be right for
Neuroendocrine NeoplasmAdenocarcinoma
European Institute of Oncology 90
Testing effectiveness (Phase 2)Looking for participantsNCT07795749
What this trial is testing

Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)

Who this might be right for
Esophageal CarcinomaGastric Cancer (Diagnosis)Colorectal Adenocarcinoma+3 more
University of California, Irvine 55
Testing effectiveness (Phase 2)Ended earlyNCT01886287
What this trial is testing

P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome

Who this might be right for
Neuroendocrine Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 2
Not applicableStudy completedNCT03771508
What this trial is testing

Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)

Who this might be right for
Small Intestine DiseaseSmall Intestine CancerSmall Intestinal Ulcer Bleeding+3 more
Medtronic - MITG 3,712
Early research (Phase 1)Study completedNCT00753415
What this trial is testing

V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Who this might be right for
Non-Small Cell Lung CarcinomaBreast CancerMelanoma+5 more
Merck Sharp & Dohme LLC 37
Not applicableStudy completedNCT04478175
What this trial is testing

Prospective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive Oncology

Who this might be right for
Non-colorectal Cancer (Esophagus, Stomach, Liver/Bile Ducts, Pancreas, Neuroendocrine Carcinoma)Colorectal With Associated Risk Factors
Institut Curie 30
Not applicableLooking for participantsNCT07500259
What this trial is testing

Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC

Who this might be right for
Colorectal CancerPDAC - Pancreatic Ductal Adenocarcinoma
Luxembourg Institute of Health 188
Testing effectiveness (Phase 2)Ended earlyNCT02241720
What this trial is testing

Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers

Who this might be right for
Upper GI Cancer
University of Utah 5
Large-scale testing (Phase 3)Study completedNCT01829178
What this trial is testing

Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma

Who this might be right for
Upper GI CancerCisplatin Adverse Reaction
Tehran University of Medical Sciences 30
Next Page